Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Green Star Products (GSPI) Message Board

GSPI: made improvements to the original (Graphene)

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 76
(Total Views: 398)
Posted On: 03/16/2022 4:24:09 PM
Posted By: Adam1
GSPI: made improvements to the original (Graphene) patent...more types of Molecules and improved the ability to make quick changes to alter molecule types



BronzeIllfatedAlabamamapturtle-size_restricted.gif


2:43 PM · Mar 16, 2022· Twitter for Android

Kristy Hunt
@CEOGSPI
Replying to

@Harry_Pooter420

Well Harry, we made improvements to the original patent while waiting for the patent to be issued. It was tested for more types of Molecules and improved the ability to make quick changes to alter molecule types. Trade secrets, so right now, all that can be shared.

2:43 PM · Mar 16, 2022· Twitter for Android



Harry Pooter
@Harry_Pooter420
·
Mar 11
I would like to hear more about this 2nd graphene prototype
when you have time





Kristy Hunt
@CEOGSPI
·
Mar 7
$GSPI is ramping up production of the repellent, sending out samples of our water soluble lubricant, ordering supplies for MNG formula, and working on a second Graphene prototype this week...going to require quite a bit of coffee. That is what is happening this week.


Source: https://twitter.com/CEOGSPI/status/1504166568...rh798pAAAA





Other Graphene Info: See Below





Neha MathurBy Neha Mathur Jan 20 2022 Reviewed by Danielle Ellis, B.Sc.

In a study published in the latest issue of the journal Materials Today Advances, a team of researchers explored the utilities of graphene (GO) and its derivatives in combating the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlighting its applications in the biomedical domain.

Study: Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection. Image Credit: Rost9/ShutterstockStudy: Potentialities of graphene and its allied derivatives to combat against SARS-CoV-2 infection. Image Credit: Rost9/Shutterstock

GO has unique mechanical, electrical, and piezoelectric capabilities and exhibits antiviral properties due to the presence of several oxygen-containing functional groups, all of which make it an ideal choice for making products for containing or treating SARS-CoV-2 infections. Notably, not only GO nanoparticles, but GO-derivatives, such as reduced graphene oxide (r-GO), fullerene, graphene quantum dots (GQDs), carbon nanotubes (CNTs), etc. are quite useful against SARS-CoV-2.

There is an urgent need to develop diagnostic devices and treatment strategies to combat the SARS-CoV-2-induced pandemic. To this end, this research paper evaluates the utilities of GO and its derivatives in the fabrication of biosensors, personal protection equipment (PPE) kits, 3-D printing, and antiviral coatings, all of which may help to combat coronavirus disease 2019 (COVID-19).
Evaluating all possible biomedical applications of graphene


Given unique optical and electrochemical behavior, excellent electrocatalytic activities, and thermal, mechanical, and electrical properties of GO and its derivatives, they have been used to design effective biosensors to detect SARS-CoV-2 in patient blood and saliva samples. The authors highlighted a research work wherein a biosensing platform used graphene-oxide-glazed double interdigitated capacitive (DIDC) to detect the spike protein (S1) of SARS-CoV-2. This electroactive immune-sensing platform was rapid, highly sensitive, and showed a wide detection range. It exhibited selectivity against blood-borne antigens and could stand for almost ten days at 5°C. Therefore, this biochip could be potentially used as a portable, rapid point-of-care (POC) method for early diagnosis of SARS-CoV-2 using clinical samples.



Source: https://www.news-medical.net/news/20220120/Pr...ction.aspx










(0)
(0)




Green Star Products (GSPI) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us